Prebiotic supplementation modulates advanced glycation end‑products (AGEs), soluble receptor for AGEs (sRAGE), and cardiometabolic risk factors through improving metabolic endotoxemia: a randomized‑controlled clinical trial

Prebiotic supplementation modulates advanced glycation end‑products (AGEs), soluble receptor for AGEs (sRAGE), and cardiometabolic risk factors through improving metabolic endotoxemia: a randomized‑controlled clinical trial


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: مهدیه عباسعلیزاد فرهنگی , پروین دهقان

کلمات کلیدی: Keywords Prebiotic · Advanced glycation end-products · Resistant dextrin · sRAGE · Lipid profle · Blood pressure · Cardiovascular diseases

نشریه: 10990 , 7 , 59 , 2019

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله پروین دهقان
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات علوم تغذیه
کد مقاله 70569
عنوان فارسی مقاله Prebiotic supplementation modulates advanced glycation end‑products (AGEs), soluble receptor for AGEs (sRAGE), and cardiometabolic risk factors through improving metabolic endotoxemia: a randomized‑controlled clinical trial
عنوان لاتین مقاله Prebiotic supplementation modulates advanced glycation end‑products (AGEs), soluble receptor for AGEs (sRAGE), and cardiometabolic risk factors through improving metabolic endotoxemia: a randomized‑controlled clinical trial
ناشر 3
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Purpose The oxidative stress plays a key role in the initiation, propagation, and development of the complications of type 2 diabetes mellitus (T2DM). This trial aimed to evaluate the efects of resistant dextrin as a prebiotic on the cardiometabolic risk factors and the status of oxidative stress in patients with T2DM. Methods Sixty-fve female subjects with T2DM were assigned to either the intervention (n=33) or control (n=32) groups receiving 10 g/day of resistant dextrin or placebo, respectively, for 8 weeks. Fasting blood samples were collected at baseline and post-intervention to determine the serum levels of glycemic indices, lipid profle, atherogenic indices, and soluble receptor for AGEs (sRAGE), carboxymethyl lysine (CML), pentosidine, malondialdehyde (MDA), 8-iso-prostaglandin F2α (8-iso-PGF2α), total antioxidant capacity (TAC), antioxidant enzymes activity, and uric acid. Data were analyzed using SPSS software 17. Paired, unpaired Student’s t tests, and analysis of covariance were used to compare the quantitative variables. Results Resistant dextrin caused a signifcant decrease in FPG (−17.43 mg/dl, 9.80%), TG (−40.25 mg/dl, 23.01%), TC/ HDL (−0.80, 21.87%), LDL-c/HDL-c (−0.80, 17.85%), Atherogenic index (−0.40, 15.80%), LPS (−6.5 EU/ml, 23.40%) and hs-CRP (−8.02 ng/ml, 54.00%), MDA (−1.21 nmol/mL, 25.58%), CML (− 93.40 ng/ml, 26.30%), 8-iso-PGF2α (−4.65 pg/ ml, 15.00%), and a signifcant increase in TAC (0.33 mmol/L, 36.25%) and s-RAGE (2.10 ng/ml, 28.90%) in the intervention group compared with the control group. No signifcant changes were observed in glycosylated hemoglobin, total cholesterol, LDL-c, HDL-c, superoxide dismutase, glutathione peroxidase and catalase, pentosidine, and uric acid in the intervention group compared with the control group. Conclusions Supplementation with resistant dextrin may improve the advanced glycation end-products, sRAGE, and cardiometabolic risk factors in women with type 2 diabetes mellitus.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
مهدیه عباسعلیزاد فرهنگیاول
پروین دهقاندوم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
PrebioticSupplementationModula.pdf1399/06/29823773دانلود